Medicare Enrolled
Dr. Mohammad Qureshi, MD
Cardiovascular Disease · Beverly Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Qureshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qureshi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qureshi
Dr. Mohammad Qureshi is a cardiovascular disease specialist in Beverly Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Qureshi performed 2,028 Medicare services across 1,203 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qureshi received a total of $47,042 from 51 pharmaceutical and/or device companies across 637 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qureshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 31% volume in MI
$47,042 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,028
Medicare services
Top 31% in MI for cardiovascular disease
1,203
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~101 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
435 | $100 | $140 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
290 | $65 | $97 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
204 | $43 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
169 | $70 | $100 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
130 | $96 | $147 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
123 | $148 | $399 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
84 | $11 | $31 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
66 | $343 | $800 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
65 | $139 | $266 |
| Cardiac catheterization | 62 | $202 | $503 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
53 | $146 | $392 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
43 | $18 | $27 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
36 | $18 | $57 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
34 | $21 | $60 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
34 | $42 | $54 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
34 | $61 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $130 | $198 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
23 | $466 | $1,105 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
23 | $30 | $117 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
21 | $196 | $421 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
16 | $47 | $60 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $269 | $650 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
14 | $48 | $155 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
12 | $9 | $25 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
12 | $21 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.2% high complexity
24.1% medium
62.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,042
Total received (2018-2024)
Avg $6,720/year across 7 years
Top 8% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
637
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27,705 (58.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,072 (34.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,265 (6.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,299
2023
$3,361
2022
$3,078
2021
$2,181
2020
$1,859
2019
$12,021
2018
$17,242
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lexicon Pharmaceuticals, Inc.
$3,265
Abbott Laboratories
$466
Amgen Inc.
$410
Lilly USA, LLC
$342
AstraZeneca Pharmaceuticals LP
$332
Boehringer Ingelheim Pharmaceuticals, Inc.
$298
Merck Sharp & Dohme LLC
$226
Novo Nordisk Inc
$202
Kestra Medical Technology Services, Inc.
$195
Janssen Pharmaceuticals, Inc
$183
E.R. Squibb & Sons, L.L.C.
$172
Esperion Therapeutics, Inc.
$168
Inari Medical, Inc.
$158
Penumbra, Inc.
$143
Impulse Dynamics (USA) Inc.
$122
Inspire Medical Systems, Inc.
$120
Bayer Healthcare Pharmaceuticals Inc.
$117
Kiniksa Pharmaceuticals International, plc
$83
SCPHARMACEUTICALS INC.
$79
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$73
Medtronic, Inc.
$63
Novartis Pharmaceuticals Corporation
$36
iRhythm Technologies, Inc.
$28
ABIOMED
$19
Top 3 companies account for 56.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$27,364
Lexicon Pharmaceuticals, Inc.
$3,265
Abbott Laboratories
$2,107
Amgen Inc.
$1,584
AstraZeneca Pharmaceuticals LP
$1,460
Janssen Pharmaceuticals, Inc
$1,185
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,120
Medical Device Business Services, Inc.
$837
E.R. Squibb & Sons, L.L.C.
$807
Lilly USA, LLC
$795
Kestra Medical Technology Services, Inc.
$757
Merck Sharp & Dohme LLC
$631
CryoLife, Inc.
$588
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$559
Novo Nordisk Inc
$554
Medtronic Vascular, Inc.
$344
Esperion Therapeutics, Inc.
$330
Medtronic, Inc.
$173
ABIOMED
$170
Inari Medical, Inc.
$158
GENZYME CORPORATION
$150
Penumbra, Inc.
$143
BARD PERIPHERAL VASCULAR, INC.
$133
CHIESI USA, INC.
$123
Impulse Dynamics (USA) Inc.
$122
Inspire Medical Systems, Inc.
$120
Bayer Healthcare Pharmaceuticals Inc.
$117
SCPHARMACEUTICALS INC.
$114
Philips Electronics North America Corporation
$111
BOSTON SCIENTIFIC CORPORATION
$100
Astellas Pharma US Inc
$100
Kiniksa Pharmaceuticals International, plc
$83
PFIZER INC.
$81
AXOGEN
$78
Opsens Inc.
$77
Gilead Sciences, Inc.
$74
Kiniksa Pharmaceuticals, Ltd.
$72
ARBOR PHARMACEUTICALS, INC.
$69
Daiichi Sankyo Inc.
$58
Regeneron Healthcare Solutions, Inc.
$51
Edwards Lifesciences Corporation
$46
iRhythm Technologies, Inc.
$46
Boston Scientific Corporation
$46
Preventice Services, LLC
$26
Bard Peripheral Vascular, Inc.
$24
Azurity Pharmaceuticals, Inc.
$21
Teleflex LLC
$17
ARALEZ PHARMACEUTICALS US INC.
$17
Merck Sharp & Dohme Corporation
$13
Amarin Pharma Inc.
$12
EKOS Corporation
$11
Top 3 companies account for 69.6% of all-time payments
Associated products mentioned in payments ›
(5027) Intact Vascular Undivided · AMPLATZER AMULET · ANDEXXA · AVANCE NERVE GRAFT · Accent Pacemaker · Arcalyst · Assure WCD · BRILINTA · CAMZYOS · Confirm Rx · Corlanor · DRAGONFLY OPSTAR · EKOSONIC · ELIQUIS · EMBLEM MRI S-ICD · ENSITE PRECISION · ENTRESTO · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FABRAZYME · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · Fortify Assura · HAWKONE · HeartMate 3 Left Ventricular Assist Device · IN.PACT ADMIRAL · IN.PACT Admiral · INJECTAFER · INSPIRE · Impella · JARDIANCE · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LUTONIX · LifeVest · MANTA · MOUNJARO · NEXLETOL · On-X · Optimizer · OptoWire · Ozempic · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · Penumbra System · RYBELSUS · Repatha · Resolute · S · SENSOR ENABLED · TACTICATH ABLATION CATHETER · TRULICITY · Unify Assura CRT Defibrillator · VERQUVO · Vascepa · Victoza · WATCHMAN · Wegovy · XARELTO · XIENCE SIERRA · ZIO XT Patch · ZONTIVITY · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (59%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for cardiovascular disease in MI.
Geographic Context
Cardiologists within 10 mi
315
Per 100K population
24.8
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE HOSPITAL, SOUTHFIELD AND NOVI
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Qureshi is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Qureshi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Qureshi performed 435 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qureshi receive payments from pharmaceutical companies?
Yes. Dr. Qureshi received a total of $47,042 from 51 companies across 637 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qureshi's costs compare to other cardiologists in Beverly Hills?
Dr. Qureshi's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qureshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Beverly Hills
Browse cardiologists in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MI
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MI
Which MI cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Lexicon Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Lexicon Pharmaceuticals, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology